NCT01721772 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 210
- group Id
- BG001
- value
- 208
- group Id
- BG002
- value
- 418
- units
- Participants
- groups
- description
- Participants received nivolumab, 3 mg/kg, solution administered Intravenously (IV) every 2 weeks with placebo-matching dacarbazine solution administered IV every 3 weeks, until disease progression, discontinuation due to toxicity, withdrawal of consent, or study completion
- id
- BG000
- title
- Nivolumab, 3 mg/kg + Placebo-matching Dacarbazine
- description
- Participants received dacarbazine 1000 mg/m\^2, solution administered IV every 3 weeks with placebo-matching nivolumab solution administered IV every 2 weeks until disease progression, discontinuation due to toxicity, withdrawal of consent, or study completion
- id
- BG001
- title
- Dacarbazine, 1000 mg/m^2 + Placebo-matching Nivolumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.00
- value
- 61.6
- group Id
- BG001
- spread
- 12.60
- value
- 63.7
- group Id
- BG002
- spread
- 12.83
- value
- 62.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 105
- group Id
- BG001
- value
- 94
- group Id
- BG002
- value
- 199
- title
- Younger than 65 years
- measurements
- group Id
- BG000
- value
- 78
- group Id
- BG001
- value
- 74
- group Id
- BG002
- value
- 152
- title
- 65 to younger than 75 years
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 67
- title
- 75 years and older
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 89
- group Id
- BG001
- value
- 83
- group Id
- BG002
- value
- 172
- title
- Female
- measurements
- group Id
- BG000
- value
- 121
- group Id
- BG001
- value
- 125
- group Id
- BG002
- value
- 246
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 209
- group Id
- BG001
- value
- 207
- group Id
- BG002
- value
- 416
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaskan native
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- All participants randomized to receive treatment
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 210
- group Id
- BG001
- value
- 208
- group Id
- BG002
- value
- 418
- units
- Participants
- groups
- description
- Participants received nivolumab, 3 mg/kg, solution administered Intravenously (IV) every 2 weeks with placebo-matching dacarbazine solution administered IV every 3 weeks, until disease progression, discontinuation due to toxicity, withdrawal of consent, or study completion
- id
- BG000
- title
- Nivolumab, 3 mg/kg + Placebo-matching Dacarbazine
- description
- Participants received dacarbazine 1000 mg/m\^2, solution administered IV every 3 weeks with placebo-matching nivolumab solution administered IV every 2 weeks until disease progression, discontinuation due to toxicity, withdrawal of consent, or study completion
- id
- BG001
- title
- Dacarbazine, 1000 mg/m^2 + Placebo-matching Nivolumab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 13.00
- value
- 61.6
- group Id
- BG001
- spread
- 12.60
- value
- 63.7
- group Id
- BG002
- spread
- 12.83
- value
- 62.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 105
- group Id
- BG001
- value
- 94
- group Id
- BG002
- value
- 199
- title
- Younger than 65 years
- measurements
- group Id
- BG000
- value
- 78
- group Id
- BG001
- value
- 74
- group Id
- BG002
- value
- 152
- title
- 65 to younger than 75 years
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 40
- group Id
- BG002
- value
- 67
- title
- 75 years and older
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 89
- group Id
- BG001
- value
- 83
- group Id
- BG002
- value
- 172
- title
- Female
- measurements
- group Id
- BG000
- value
- 121
- group Id
- BG001
- value
- 125
- group Id
- BG002
- value
- 246
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 209
- group Id
- BG001
- value
- 207
- group Id
- BG002
- value
- 416
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaskan native
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- All participants randomized to receive treatment
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle